Other

Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr

Vsesojuzny Nauchno-issledovatelsky I Ispytateiny Institut Meditsinskoi

Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskiki Nauk

Gennady L Khromov

Anatoly B Davydov

Rustam I Utyamyshev

Vladimir I Metelitsa

Eduard A Babaian

Konstantin L Savvateev

Elizaveta B Novikova

Anatoly M Vikhert

Galina A Gerasimova

Vladimir K Piotrovsky

Jury Fedorovich Maichuk

Sergei I Belykh

Evgeny I Chazov

Anatoly D Moschensky

Gely G Pershin

Antonina A Dolgopyatova

Inna Fedorovna Tishina

Eduard S Avetisov

Inna Fedorovna Tischina

Maya I Vinetskaya

Gennady I Roitberg

Gennady L Voskresensky

Elena N Iomdina

Ilya A Movshovich

Zulfia K Boltaeva

Valery A Moskvitin

Ljudmila D Andreeva

Tamara P Ostrovskaya

Elena P Tarutta

Composition for treatment of progressive myopia

An antianginal composition in the form of a plate is provided for treating ischemic heart disease and is comprised of a biologically soluble and resolvable film and an antianginal coronary vasodilating nitrate. This film is placed buccally on the gum or mouth mucosa for rapid arresting or prevention of angina pectoris attacks. The antianginal film is in the form of a plate, 0.1 to 1.5 mm thick, consisting of a biologically soluble and resolvable carrier. Preferably, the film is comprised of a homoploymer of acrylamide or vinylpyrrolidone, or a copolymer thereof with acrylate, containing from 99 to 70 percent by weight of acrylamide with vinylpyrrolidone and from 1 to 30 percent by weight of acrylate having a molecular mass from 50,000 to 1,000,000, and the active principle having antianginal action, the components being taken in the following proportions, in percent by weight:

Antianginal plate for treating ischemic heart disease

An antianginal composition in the form of a plate is provided for treating ischemic heart disease and is comprised of a biologically soluble and resolvable film and an antianginal coronary vasodilating nitrate. This film is placed buccally on the gum or mouth mucosa for rapid arresting or prevention of angina pectoris attacks. The antianginal film is in the form of a plate, 0.1 to 1.5 mm thick, consisting of a biologically soluble and resolvable carrier. Preferably, the film is comprised of a homopolymer of acrylamide or vinylpyrrolidone, or a copolymer thereof with acrylate, containing from 99 to 70 percent by weight of acrylamide with vinylpyrrolidone and from 1 to 30 percent by weight of acrylate having a molecular mass from 50,000 to 1,000,000 and the active principle having antianginal action, the components being taken in the following proportions, in percent by weight:

The antianginal film is a plate, 0.1 to 1.5 thick, consisting of a biologically soluble and resolvable carrier, which is a hompolymer of acrylamide or vinylpyrrolidone, or a copolymer thereof with acrylate, containing from 99 to 70 percent by weight of acrylamide with vinylpyrrolidone and from 1 to 30 percent by weight of acrylate having a molecular mass from 50,000 to 1,000,000, and the active principle having antianginal action, the components being taken in the following proportions, in percent by weight:

Antianginal film and method of treating ischemic heart disease

A pharmaceutical preparation for the treatment of diabetes mellitus comprising the following components, in percent by weight:

Pharmaceutical composition for the treatment of diabetes mellitus

This invention relates to medical technique and more particularly it relates to biodestructive materials used to manufacture elements for fixation of bone fragments. Said material contains a matrix of non-toxic polymer resolvable in the body consisting of hydrophilic and hydrophobic repeat units, and a reinforcing component of non-toxic fibres or threads resolvable in the body. The matrix polymer is preferably a copolymer of methyl methacrylate and N-vinyl pyrrolidone, and the reinforcing component is preferably fibre or threads of polyamide and oxycellulose. Said material can be used in medicine for fixation of bone fragments in fractures or injuries of bones.

Biodestructive material for bone fixation elements

A base for ophthalmological medicinal preparations consists of a homopolymer of an amide of acrylic acid having a molecular weight from 30,000 to 1,000,000, and/or a copolymer of an amide of acrylic acid with unsaturated compounds, the molecular weight of the copolymer being from 20,000 to 500,000, and containing from 10 to 90 per cent acrylamide links. The ophthalmological medicinal film is an oblong plate, 6-9 mm long, 3-5 mm wide and 0.2-0.6 mm thick, of the homopolymer and/or copolymer acrylamide links from 10 to 90 per cent, and an active medicinal ingredient, viz., 3-ethyl-4(1-methyl-5-imidazolyl)-tetrahydrofuran-2-one or atropine, or 3-methoxy-6-sulphanilan idopyridazine, or .beta.-dimethylamino-ethyl-p-butylaminobenzoate, or neamine, or 5-iodo-2-desoxyuridine. The ophthalmological medicinal film is used for treatment of glaucoma of various forms, thrombosis of the central vein of the retina, atrophy of the optic nerve, for dilating the pupil and paralysis of accommodation in treatment of keratitis, iritis, iridocyclitis, ulcers of the cornea, trachoma, herpetic keratitis, uveitis and adenoviral infections, in extraction of foreign objects from the eye, and in various interventions in the organ of vision.

Base for ophthalmological medicinal preparation on opthalmological

A base for ophthalmological medicinal preparations consists of a homopolymer of an amide of acrylic acid having a molecular weight from 30,000 to 1,000,000, and/or a copolymer of an amide of acrylic acid with unsaturated compounds, the molecular weight of the copolymer being from 20,000 to 500,000, and containing from 10 to 90 percent acrylamide links. The ophthalmological medicinal film is an oblong plate, 6-9 mm long, 3 - 5 mm wide and 0.2 - 0.6 mm thick, of the hompolymer and/or copolymer and an active medicinal ingredient, viz., 3-ethyl-4(1-methyl-5-imidazolyl)-tetrahydrofuran-2-one or atropine, or 3-methoxy-6-sulfanilam idopyridazine, or .beta.-dimethylamino-ethyl-p-butylaminobenzoate, or neamine, or 5-iodo-2-desoxyuridine. The ophthalmological medicinal film is used for treatment of glaucoma of various forms, thrombosis of the central vein of the retina, atrophy of the optic nerve, for dilating the pupil and paralysis of accommodation in treatment of keratitis, iritis, iridocyclitis, ulcers of the cornea, trachoma, herpetic keratitis, uveitis and adenoviral infections, in extraction of foreign objects from the eye, and in various interventions in the organ of vision.

Base for ophthalmological medicinal preparations and on ophthalmological

Growing community of inventors

Moscow, Russia

Gennady L Khromov